Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/13/13 → 06/12/14 |
Funding
- Vertex Pharmaceuticals Incorporated: $141,385.48
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous
- Frederick, Carla (PI)
Project: Research